Sleep Apnea Devices Market Size Share Analysis 2022-2029

Increasing Awareness Among the Patient Population 

Increasing the awareness and improving the diagnosis and treatment of sleep disorders necessitates a multipronged effort that includes three key components: public education, training for health professionals, and surveillance and monitoring.

Clinicians frequently recommend a good night's sleep for their patients but rarely focus on the issue when seeing them in the clinical setting. Sleep problems may also be increasing in developing nations as a recent study suggested that almost 17% of patients surveyed across eight countries in Asia and Africa reported trouble with sleep (as per NCBI).

A review of the National Center on Sleep Disorders Research (NCSDR), Centers for Disease Control and Prevention (CDC), and private foundations demonstrate a limited investment in education and awareness campaigns directed toward increasing the general public’s knowledge of the health implications associated with chronic sleep loss and sleep disorders.

The Garfield Star Sleeper Campaign was designed to educate children, parents, educators, and health care providers about the importance of nighttime sleep during childhood.

Time For Kids is a magazine on sleep that was developed and distributed by the NCSDR to 30,000 third-grade teachers and the 750,000 children in their classes in connection with National Sleep Awareness Week.

Sleep, Sleep Disorders, and Biological Rhythms is a curriculum supplement developed for grades 9 through 12 (NHLBI). Approximately 12,000 copies of the curriculum supplement have been sent to teachers. There have been more than 11,000 visitors to the sleep curriculum website and 10,000 downloads. More than 2,000 students entered sleep diary data on the Internet.

Large Pool Of Undiagnosed Sleep Apnea Patients

The massive pool of undiagnosed patients of sleep apnea holds tremendous potential for the sleep apnea devices market. It is expected with the ongoing awareness campaigns and efforts, the untouched patient base would be diagnosed and treated for the sleep apnea. 

According to sleepassociation.org, it is known that obstructive sleep apnea is a prevalent condition, which affects up to 20% of the world population. It is a serious and life-threatening sleep illness that usually goes undiagnosed and untreated.

However, various government initiatives are helping patients who suffer from sleep apnea. For instance, in the United States, the American Sleep Apnea Association (ASAA) was founded in 1990, which is a non-profit organization that promotes awareness regarding sleep apnea, works for continuing improvements in treatments, and advocates for the interests of sleep apnea patients. Thus, the above-mentioned factors are boosting market growth.

Moreover, people with obesity and hypertension are more likely to develop sleep apnea. As per the analysis made by CDC, the prevalence of obesity in the U.S is 39.8%, accounting for nearly 93.3 million adults in 2015-2016.

According to WHO in 2019, more than 50% of men and women living in Europe were estimated to be overweight. The average obesity rate in the region is 23.3%. Hence, the number of people affected is likely to increase over the forecast period. 

Upcoming Technological Advancements

• The development of new technologies for the treatment and diagnosis of the disease is driving market growth. Moreover, new alternatives to CPAP equipment such as nasal and oral equipment are developed for patients with low CPAP tolerance. 
• For instance, In February 2021, GoPAPFree, a homecare oral devices manufacturer for OSA, launched O2 Vent Optima to serve as an effective and more convenient CPAP alternative. This device increases sleep apnea therapy response by 40.0%. 
• In February 2020, Fisher and Paykel launched F&P Evora with CapFit headgear, a compact nasal mask for treating sleep apnea. The company launched this product in the markets of New Zealand, Europe, Australia, and Canada.
• With the rising technological advancements and product innovations, mid-size and small-scale companies are increasing their market presence by introducing new devices into the market at competitive prices. Companies, like Resmed, Fisher & Paykel Healthcare Limited, and Invacare Corporation, hold substantial shares in the market.
• For instance, in 2019, ResMed launched AirFit N30i, its first top-of-head-connected nasal CPAP mask, across the U.S. with a newly designed nasal cradle cushion that sits just under the wearer’s nose.
• The trend is shifting towards mHealth apps for remote monitoring of sleep, enhancement of patient outcomes, and real-time screening of patient data. Detection of symptoms of sleep apneaare done by the built-in sensor technology available in smartphones. These factors are driving the market growth in the forecast period.

About Us:

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: [email protected]

Tel: +1 877 441 4866

Website: www.datamintelligence.com